Ignite Creation Date:
2025-12-24 @ 12:39 PM
Ignite Modification Date:
2026-01-29 @ 1:23 AM
Study NCT ID:
NCT01190761
Status:
COMPLETED
Last Update Posted:
2010-08-30
First Post:
2010-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
40464
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Meena Venugopal, Director, Clinical R&D
Old Organization:
Actavis Inc